Breast Implants

Heart Bypass Surgery Drug Causing Kidney/Renal Failure Suspended; Anapol Schwartz Attorney -- Representing Victims -- Says Situation Could Be Next Baycol

Published in Women's Health Weekly, November 22nd, 2007

According to James Ronca of law firm Anapol, Schwartz, Weiss, Cohan, Feldman & Smalley, P.C., Bayer AG's announcement today that it would suspend sales of blood-clotting drug Trasylol(R), could lead to a situation in which it becomes the next Baycol. Trasylol(R) is used in coronary artery bypass graft (CABG) procedures and found to cause kidney/renal failure.

Ronca represents more than a dozen families and alleged victims in this growing area of litigation, and recently filed a Trasylol(R) lawsuit - a wrongful death complaint in Philadelphia.

"This should have been prevented. Again, we have an example of a highly expensive drug that was put on the...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Source: Women's Health Weekly (2007-11-22)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry